Dreaming - the Breast Cancer Vaccine

I have a dream. Well, I have lots of dreams, but this is an easy, almost painless way to ensure that no woman ever to face or fight to survive breast cancer opet.Cjepivo. Am I only dreaming? Maybe. Maybe not.

Mouse dairy tumor virus (MMTV) is a proven cause of breast cancer in experimental and field mice. MMTV was discovered way back in 1936. MMTV like virus genetic material has been identified in human breast tumors, but it is not known whether it actually causes tumor development. Research has revealed the human mammary tumor virus, HMTV, which is 95-98% similar to the mouse virus (MMTV), so it is believed that the same virus.

HMTV was found in about 40 percent of all human breast cancer (BC) specimens examined, in 60 percent of pregnancies associated bc-, and 71 percent of inflammatory bc-a. Women whose tumors showed evidence of virus antibodies by 95 percent of the time, when normal, healthy women have antibodies to the virus, less than 5 percent of the time.

of the research team, led by Vincent Tuohy, Ph.D., at the Cleveland Clinic Lerner Research Institute, have developed a vaccine that prevents breast cancer tumors from forming in mice and inhibits the growth of existing tumora.Cjepivo contains the antigen-lactalbumin. In the latest study, genetically cancer-prone mice were vaccinated - half with the vaccine containing the antigen and a half a vaccine that contains antigen. None of the mice vaccinated with the antigen developed breast cancer, while all other mice did.

Unlike the FDA approved a vaccine against cervical cancer and liver cancer vaccines, both of which target the virus (human papilloma virus and hepatitis B virus), this mouse vaccine targets cancer formation itself. Tuohy explains that the key to developing a vaccine for human breast cancer is, therefore, to find the target in a tumor that is usually found in healthy people. In the case of breast cancer, they are targeting-lactalbumin, a protein found in most breast cancers, but not in healthy women, except during dojenja.Cjepivo is expected to stimulate the female's immune system to target a-lactalbumin, stopping tumor without damaging healthy breast tissue.

hoped for a strategy to vaccinate women over 40, when the risk of breast cancer begins to grow and become pregnant less vjerojatno.Cjepivo would also be an alternative option for younger women with increased risk of breast cancer, rather than prophylactic mastectomy.

Although there is still controversy as breast cancer contain a-lactalbumin, Tuohy hopes that his discovery could lead to vaccines for other cancers, and so I gave him the vaccine is ready to be tested for safety in humans, but guess it. Commented it refused to fund 3 times and Avon refused to even consider. Hmmmm .... Perhaps Mr. Tuohy Queen pinkwashing scared when he said, "" If it works in humans the way it works in mice, it will be monumental. We could eliminate breast cancer ."

I first heard about the possibility of one or more of the virus from breast cancer by Dr. Kathleen Ruddy, founder of the Breast Health and Healing Foundation. Talk about the health of the host a question / answer session with Dr. rumen, which is a great place to start if you're interested in learning more about this subject.

Susan Beausang, 4Women.com